Strides Pharma Science Ltd reported consolidated revenue of ₹11.95 billion and net profit of ₹2.02 billion for the December quarter. The robust results highlight strong demand in generics and specialty pharmaceuticals, reinforcing Strides’ position as a key player in India’s pharmaceutical growth story.
Show moreStay Ahead – Explore Now! India Gears Up for Massive ₹580 Bn Bond Auction: Key 2040 & 2065 Securities in Focus
Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.
Powered By Just Imagine
